Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

A Stable Renewable Fuel Standard Is Needed to Meet Biofuel Production Goals, BIO Says
Nov 2 2011
Advanced biofuels companies continue to make progress in bringing new technology to the fuels market, relying on consistent implementation of the Renewable...
BIO Praises Passage of Small Company Capital Formation Act
Nov 2 2011
Washington, DC (November 2, 2011) – The Biotechnology Industry Organization (BIO) strongly supports the Small Company Capital Formation Act (HR 1070),...
BIO Applauds Sen. Stabenow’s Bill to Extend Advanced Energy Project Credit to Renewable Chemicals and Biobased Products
Nov 2 2011
Biobased products and renewable chemicals can contribute to energy security and create new jobs and so should be eligible for advanced energy project credits...
BIO Announces Key Senior Staff Hires
Oct 28 2011
WASHINGTON, D.C. (October 28, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood announced today two outstanding new...
Missouri Science and Innovation Reinvestment Act Will Spur Economic Growth
Oct 26 2011
WASHINGTON, D.C. (October 26, 2011) – Missouri Governor Jay Nixon signed Senate Bill 7, the Missouri Science and Innovation Reinvestment Act (MOSIRA)...
BIO Expresses Strong Support for Timely Reauthorization of PDUFA
Oct 24 2011
Washington, D.C. (October 24, 2011) – The Biotechnology Industry Organization (BIO) provided a statement of support for the Prescription Drug User Fee...
Pacific Rim Summit to Highlight U.S.-Asia Partnership Opportunities for Biofuels, Renewable Chemicals
Oct 19 2011
The 2011 Pacific Rim Summit on Industrial Biotechnology and Bioenergy will feature two technical tracks for exploring partnership opportunities between...
BIO Applauds the Intent to Create a National Bioeconomy Blueprint
Oct 13 2011
Washington, D.C. (October 13, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the...
10th Annual BIO Investor Forum Business Roundtables Highlight Innovative Strategies in Deal-Making and Investments
Oct 11 2011
WASHINGTON, DC – (October 11, 2011) – The Biotechnology Industry Organization (BIO) today announces Business Roundtables planned for the...
BIO Statement on U.S. District Court Ruling in “Eucalyptus” Case
Oct 7 2011
Washington, D.C. (October 7, 2011) – In a case brought against USDA’s Animal and Plant Health Inspection Service (APHIS) by a coalition of...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...